The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)—Chemistry, Bioavailability, and Metabolism
Open accessAbstract
Milk thistle (Silybum marianum) is a medicinal plant that has been used for thousands of years as a remedy for a variety of ailments. The main component of S. marianum fruit extract (silymarin) is a flavonolignan called silybin, which is not only the major silymarin element but is also the most active ingredient of this extract, which has been confirmed in various studies. This compound belongs to the flavonoid group known as flavonolignans. Silybin’s structure consists in two main units. The first is based on a taxifolin, the second a phenyllpropanoid unit, which in this case is conyferil alcohol. These two units are linked together into one structure by an oxeran ring. Since the 1970s, silybin has been regarded in official medicine as a substance with hepatoprotective properties. There is a large body of research that demonstrates silybin’s many other healthy properties, but there are still a lack of papers focused on its molecular structure, chemistry, metabolism, and novel form of administration. Therefore, the aim of this paper is a literature review presenting and systematizing our knowledge of the silybin molecule, with particular emphasis on its structure, chemistry, bioavailability, and metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microemulsion-based media as novel drug delivery systems
Lawrence, M. J., & Rees, G. D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00103-4 · Cited by 2,040
Pouton, C. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00167-6 · Cited by 1,230
Constantinides, P. P. (1995) · Pharmaceutical Research · doi:10.1023/a:1016268311867 · Cited by 742
The Use of Silymarin in the Treatment of Liver Diseases
Saller, R., Meier, R., & Brignoli, R. (2001) · Drugs · doi:10.2165/00003495-200161140-00003 · Cited by 718
Milk thistle in liver diseases: past, present, future
Abenavoli, L., Capasso, R., Milic, N., & Capasso, F. (2010) · Phytotherapy Research · doi:10.1002/ptr.3207 · Cited by 599
Silybin and Silymarin - New and Emerging Applications in Medicine
Gazak, R., Walterova, D., & Kren, V. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707779941159 · Cited by 573
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
Federico, A., Dallio, M., & Loguercio, C. (2017) · Molecules · doi:10.3390/molecules22020191 · Cited by 492
Silybin and silymarin - new effects and applications
Křen, V., & Walterová, D. (2005) · Biomedical Papers · doi:10.5507/bp.2005.002 · Cited by 446
Silybin and the liver: From basic research to clinical practice
Loguercio, C. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i18.2288 · Cited by 375
Charman, S. A., Charman, W. N., Rogge, M. C., Wilson, T. D., Dutko, F. J., & Pouton, C. W. (1992) · Pharmaceutical Research · doi:10.1023/a:1018987928936 · Cited by 374
Westergaard, H., & Dietschy, J. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108465 · Cited by 342
Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system
Wu, W., Wang, Y., & Que, L. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.12.005 · Cited by 291
Kim, N.-C., Graf, T. N., Sparacino, C. M., Wani, M. C., & Wall, M. E. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b300099k · Cited by 278
Patel, A. R., & Vavia, P. R. (2007) · The AAPS Journal · doi:10.1208/aapsj0903041 · Cited by 273
Lee, D. Y.-W., & Liu (2003) · Journal of Natural Products · doi:10.1021/np030163b · Cited by 242
Reassessing bioavailability of silymarin.
Javed, S., Kohli, K., & Ali, M. (2011) · PubMed · Cited by 233
Barzaghi, N., Crema, F., Gatti, G., Pifferi, G., & Perucca, E. (1990) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190223 · Cited by 226
An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
Saller, R., Brignoli, R., Melzer, J., & Meier, R. (2008) · Forschende Komplementärmedizin / Research in Complementary Medicine · doi:10.1159/000113648 · Cited by 214
Biedermann, D., Vavříková, E., Cvak, L., & Křen, V. (2014) · Nat. Prod. Rep. · doi:10.1039/c3np70122k · Cited by 196
SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
Sridar, C., Goosen, T. C., Kent, U. M., Williams, J. A., & Hollenberg, P. F. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.6.587 · Cited by 192
Salmi, H. A., & Sarna, S. (1982) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528209182242 · Cited by 190
Wu, J.-W., Lin, L.-C., Hung, S.-C., Chi, C.-W., & Tsai, T.-H. (2007) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2007.06.026 · Cited by 189
Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies
Parveen, R., Baboota, S., Ali, J., Ahuja, A., Vasudev, S. S., & Ahmad, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.041 · Cited by 166
Venkataramanan, R., Ramachandran, V., Komoroski, B. J., Zhang, S., Schiff, P. L., & Strom, S. C. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15071-4 · Cited by 156
Milk thistle: Silybum marianum
Pepping, J. (1999) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/56.12.1195 · Cited by 153
Hawke, R. L., Schrieber, S. J., Soule, T. A., Wen, Z., Smith, P. C., Reddy, K. R., Wahed, A. S., Belle, S. H., Afdhal, N. H., Navarro, V. J., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009347475 · Cited by 152
Formulation and biopharmaceutical evaluation of silymarin using SMEDDS
Woo, J. S., Kim, T.-S., Park, J., & Chi, S. (2007) · Archives of Pharmacal Research · doi:10.1007/bf02977782 · Cited by 143
Effect of Silybin and its congeners on human liver microsomal cytochrome P450 activities
Zuber, R., Modrianský, M., Dvořák, Z., Rohovský, P., Ulrichová, J., Šimánek, V., & Anzenbacher, P. (2002) · Phytotherapy Research · doi:10.1002/ptr.1000 · Cited by 139
Inhibitory Effects of Silibinin on Cytochrome P‐450 Enzymes in Human Liver Microsomes
Beckmann‐Knopp, S., Rietbrock, S., Weyhenmeyer, R., Böcker, R. H., Beckurts, K. T. E., Lang, W., Hunz, M., & Fuhr, U. (2000) · Pharmacology & Toxicology · doi:10.1111/j.0901-9928.2000.860602.x · Cited by 136
Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease
Hackett, E. S., Twedt, D. C., & Gustafson, D. L. (2012) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12002 · Cited by 125
Pharmacokinetic studies with silymarin in human serum and bile.
Lorenz, D., Lücker, P. W., Mennicke, W. H., & Wetzelsberger, N. (1984) · PubMed · Cited by 114
Lee, J. I., Narayan, M., & Barrett, J. S. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.07.063 · Cited by 108
In vitroandin vivoevaluation of silybin nanosuspensions for oral and intravenous delivery
Wang, Y., Zhang, D., Liu, Z., Liu, G., Duan, C., Jia, L., Feng, F., Zhang, X., Shi, Y., & Zhang, Q. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/15/155104 · Cited by 100
Weyhenmeyer, R., Mascher, H. J., & Birkmayer, J. G. D. (1992) · PubMed · Cited by 99
Rickling, B., Hans, B., Kramarczyk, R., Krumbiegel, G., & Weyhenmeyer, R. (1995) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(95)00168-9 · Cited by 84
Intestinal transport of bile acids
Wilson, F. A. (1981) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1981.241.2.g83 · Cited by 82
Yang, G., Zhao, Y., Zhang, Y., Dang, B., Liu, Y., & Feng, N. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s92665 · Cited by 79
Polyphenol compounds belonging to flavonoids inhibit activity of coagulation factor X
Bijak, M., Ponczek, M. B., & Nowak, P. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.01.023 · Cited by 77
Self-citationLi, X., Yuan, Q., Huang, Y., Zhou, Y., & Liu, Y. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9432-x · Cited by 76
Silybin Is Metabolized by Cytochrome P450 2C8 in Vitro
Jančová, P., Anzenbacherová, E., Papoušková, B., et al. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016410 · Cited by 72
Bioavailability of a silybin–phosphatidylcholine complex in dogs
Filburn, C. R., KETTENACKER, R., & GRIFFIN, D. W. (2007) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2007.00834.x · Cited by 61
The Effects of Milk Thistle (Silybum marianum) on Human Cytochrome P450 Activity
Kawaguchi‐Suzuki, M., Frye, R. F., Zhu, H., Brinda, B. J., Chavin, K. D., Bernstein, H. J., & Markowitz, J. S. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.057232 · Cited by 60
Sario, A. D., Bendia, E., Taffetani, S., Omenetti, A., Candelaresi, C., Marzioni, M., Deminicis, S., & Benedetti, A. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2005.05.011 · Cited by 57
Comparative bioavailability of silibinin in healthy male volunteers
Kim, Y. C., Kim, E. J., Lee, E. D., Kim, J. H., Jang, S. W., Kim, Y. G., Kwon, J.-T., Kim, W. B., & Lee, M. (2003) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp41593 · Cited by 56
Stereoselective metabolism of silybin diastereoisomers in the glucuronidation process
Han, Y. H., Lou, H. X., Ren, D., Sun, L. R., Ma, B., & Ji, M. (2004) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2003.12.002 · Cited by 47
O'Reilly, J. R., Corrigan, O. I., & O’Driscoll, C. M. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90142-2 · Cited by 45
van Wenum, E., Jurczakowski, R. R., & Litwinienko, G. (2013) · The Journal of Organic Chemistry · doi:10.1021/jo401296k · Cited by 43
Gunaratna, C., & Zhang, T. (2003) · Journal of Chromatography B · doi:10.1016/s1570-0232(03)00484-7 · Cited by 37
Flavonolignans inhibit the arachidonic acid pathway in blood platelets
Bijak, M., & Saluk, J. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1897-7 · Cited by 37
Self-citationRainone, F. (2005) · PubMed · Cited by 36
Flavonolignans inhibit ADP induced blood platelets activation and aggregation in whole blood
Bijak, M., Szelenberger, R., Saluk, J., & Nowak, P. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.12.002 · Cited by 34
Self-citationFlavonolignans reduce the response of blood platelet to collagen
Bijak, M., Dziedzic, A., & Saluk, J. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.08.091 · Cited by 30
Self-citationLi, W., Gao, J., Zhao, H., & Liu, C. (2006) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190466 · Cited by 21
Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes
Bijak, M., Dziedzic, A., Synowiec, E., Śliwiński, T., & Saluk, J. (2017) · Nutrients · doi:10.3390/nu9091022 · Cited by 21
Self-citationSilymarin, Natural Flavonolignans from Milk Thistle
AbouZid, S. F. (2012) · InTech eBooks · doi:10.5772/26027 · Cited by 18
Lv, Q., Li, X.-Y., Shen, B., Dai, L., Xu, H., Shen, C., Yuan, H.-L., & Han, J. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2455-6 · Cited by 17
Cited by
Tungmunnithum, D., Thongboonyou, A., Pholboon, A., & Yangsabai, A. (2018) · Medicines · doi:10.3390/medicines5030093 · Cited by 1,969
Sun, W., & Shahrajabian, M. H. (2023) · Molecules · doi:10.3390/molecules28041845 · Cited by 806
Antidiabetic Potential of Medicinal Plants and Their Active Components
Salehi, B., Ata, A., V. Anil Kumar, N., Sharopov, F., Ramírez-Alarcón, K., Ruiz-Ortega, A., Abdulmajid Ayatollahi, S., Valere Tsouh Fokou, P., Kobarfard, F., Amiruddin Zakaria, Z., et al. (2019) · Biomolecules · doi:10.3390/biom9100551 · Cited by 747
Abenavoli, L., Izzo, A. A., Milić, N., Cicala, C., Santini, A., & Capasso, R. (2018) · Phytotherapy Research · doi:10.1002/ptr.6171 · Cited by 463
Metadata
- Authors
- Bijak, M.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2017-11-10
- Volume
- 22
- Issue
- 11
- Pages
- 1942
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2767755407
- Cited by
- 414
- References
- 56
- FWCI
- 15.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.